{
    "root": "360950f4-eef0-54cb-e063-6394a90aa5d6",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "GABAPENTIN",
    "value": "20250526",
    "ingredients": [
        {
            "name": "COPOVIDONE K25-31",
            "code": "D9C330MD8B",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_78913"
        },
        {
            "name": "HYPROMELLOSE 2910 (5 MPA.S)",
            "code": "R75537T0T4",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "LECITHIN, SOYBEAN",
            "code": "1DI56QDM62",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_61995"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "POLYETHYLENE GLYCOL, UNSPECIFIED",
            "code": "3WJQ0SDW1A",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "POLYETHYLENE GLYCOL 3350",
            "code": "G2M7P15E5P",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "POLYVINYL ALCOHOL, UNSPECIFIED",
            "code": "532B59J990",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30879"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32178"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "HYPROMELLOSE 2208 (4000 MPA.S)",
            "code": "39J80LT57T",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "GABAPENTIN",
            "code": "6CW7F3G59X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_42797"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        }
    ],
    "indications": {
        "text": "gabapentin tablets indicated management postherpetic neuralgia . gabapentin tablets substitutable gabapentin products differing pharmacokinetic profiles affect frequency .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "gabapentin tablets titrated 1,800 mg dose taken orally , once-daily , evening meal . gabapentin tablets swallowed whole . crush , split , chew tablets . ( 2.1 ) gabapentin tablets dose reduced , discontinued , substituted alternative medication , done gradually minimum 1 week longer ( discretion prescriber ) . ( 2.1 ) renal impairment : dose adjusted patients reduced renal function . gabapentin tablets used patients crcl less 30 patients hemodialysis . ( 2.2 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "gabapentin tablets supplied follows : 300 mg tablets : gabapentin 300 mg tablets white color , oval-shaped , film coated tablets debossed \u201c g5 \u201d one side \u201c v1 \u201d side . ndc 31722-091-90 ( bottle 90 ) 600 mg tablets : gabapentin 600 mg tablets yellow color , oval-shaped , film coated tablets debossed \u201c g7 \u201d one side \u201c v1 \u201d side . ndc 31722-092-90 ( bottle 90 ) storage store 20\u00bac 25\u00bac ( 68\u00baf 77\u00baf ) ; excursions permitted 15\u00bac 30\u00bac ( 59\u00baf 86\u00baf ) [ usp controlled room temperature ] . keep reach children .",
    "adverseReactions": "gabapentin contraindicated patients demonstrated hypersensitivity ingredients .",
    "indications_original": "Gabapentin tablets are indicated for the management of postherpetic neuralgia. \n    Gabapentin tablets are not substitutable\u00a0with other gabapentin products because of differing pharmacokinetic profiles that affect the frequency of administration.",
    "contraindications_original": "Gabapentin tablets should be titrated to an 1,800 mg dose taken orally, once-daily, with the evening meal. Gabapentin tablets should be swallowed whole. Do not crush, split, or chew the tablets. ( 2.1 ) If gabapentin tablets dose is reduced, discontinued, or substituted with an alternative medication, this should be done gradually over a minimum of 1 week or longer (at the discretion of the prescriber). ( 2.1 ) Renal impairment: Dose should be adjusted in patients with reduced renal function. Gabapentin tablets should not be used in patients with CrCl less than 30 or in patients on hemodialysis. ( 2.2 )",
    "warningsAndPrecautions_original": "Gabapentin tablets are supplied as follows:\n                  \n                     \n                        300 mg tablets:\n                        \n                           \u00a0\n                        \n                          Gabapentin 300 mg tablets are white color, oval-shaped, film coated tablets debossed with \u201cG5\u201d on one side and \u201cV1\u201d on other side.\n \n  \n                  \n                  \n                  NDC 31722-091-90 (Bottle of 90)\n                  \n                     \n                        600 mg tablets:\n                        \n                          Gabapentin 600 mg tablets are yellow color, oval-shaped, film coated tablets debossed with \u201cG7\u201d on one side and \u201cV1\u201d on other side.\n \n  \n                  \n                  \n                  NDC 31722-092-90 (Bottle of 90) \n  \n                     \n                        Storage\n                     \n                       Store at 20\u00baC to\u00a025\u00baC (68\u00baF to\u00a077\u00baF); excursions permitted to 15\u00baC to 30\u00baC (59\u00baF to 86\u00baF) [see USP Controlled Room Temperature]. \n    Keep out of reach of children.",
    "adverseReactions_original": "Gabapentin is contraindicated in patients with demonstrated hypersensitivity to the drug or its ingredients.",
    "drug": [
        {
            "name": "GABAPENTIN",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_42797"
        }
    ]
}